Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apple-cure is an effervescent tablet formulated as a combination product containing pectin, niacin, and apple cider vinegar. It is being investigated for its hypolipidemic effects, aiming to improve serum lipid profiles by significantly reducing total cholesterol, triglycerides, and LDL-cholesterol levels, while simultaneously elevating HDL-cholesterol levels. Its mechanism of action is attributed to the synergistic effects of its components, with apple cider vinegar potentially influencing the glycemic index and activating hepatic AMP-activated protein kinase (AMPK), and pectin acting as a dietary fiber that modulates cholesterol metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apple-cure.